Objective To study fluorodeoxyglucose (FDG) uptake in the different vascular beds and in
the large joints of patients with giant cell arteritis (GCA) at diagnosis, during steroid treatment, …

Background Epidemiological changes and the ongoing expansion of the diagnostic
armamentarium warrant a regular update of the spectrum of diseases that present as prolonged …

Background: Recent studies have suggested that 18 fluoro-deoxyglucose (FDG) positron
emission tomography (PET) may be useful in the work-up of patients with fever of unknown …

Objective Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE)
that is usually treated with an extended course of intravenous (IV) cyclophosphamide (…

Objective In the Euro‐Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were
randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 …

Objective To develop and validate revised classification criteria for granulomatosis with
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into …

Objective To develop and validate revised classification criteria for eosinophilic granulomatosis
with polyangiitis (EGPA). Methods Patients with vasculitis or comparator diseases were …

Objective To develop and validate classification criteria for microscopic polyangiitis (MPA).
Methods Patients with vasculitis or comparator diseases were recruited into an international …

Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised
prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) …

Background Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and the
prolonged use of glucocorticoids is associated with side effects. The effect of the interleukin…